Amanyi-Enegela Juliana Ajuma, Kumbur Joseph, Okunade Faizah, Ashikeni Donald, Ishaya Rinpan, Sankar Girija, Adamani William Enan, Aderogba Moses, Makau-Barasa Louise, Emmanuel Achai, Ogundipe Bosede Eunice, Okoye Chinwe, Qureshi Babar
CBM Christian Blind Mission, Wellington house, Cambridge, UK.
CBM Christian Blind Mission Okemesi Crescent Garki 2, Abuja, Nigeria.
Infect Dis Poverty. 2025 Jul 9;14(1):63. doi: 10.1186/s40249-025-01333-5.
Nigeria's Federal Capital Territory (FCT) launched annual mass drug administration (MDA) in its four lymphatic filariasis (LF)-endemic councils in 2011, achieving sustained high coverage and pre-transmission assessment survey success. This study aimed to confirm transmission interruption in Bwari and Gwagwalada and to evaluate post-MDA surveillance efficacy in Abaji and Kuje.
Transmission Assessment Surveys (TAS) were systematically conducted in four distinct evaluation units (EUs) within the FCT. TAS 1 was carried out in Bwari and Gwagwalada EUs that had recently achieved pre-TAS thresholds indicating potential interruption of transmission, whereas TAS 2 was conducted in Abaji and Kuje EUs, where MDA had been discontinued since 2021 following successful TAS 1 evaluations. Abbott Filarial Test Strips (FTS) were employed to test children aged 6-7 years attending selected schools. Data collection adhered to standardized WHO guidelines, utilizing both paper-based and electronic data-capture tools to enhance accuracy and reduce human error.
A total of 6,448 children participated in surveys across the four EUs, with gender distribution closely balanced (53% male, 47% female). In TAS 1 (Bwari and Gwagwalada), no LF-positive cases were identified well below the WHO-defined critical cutoff of 18 cases. In TAS 2 (Abaji and Kuje), a single LF-positive case was detected in Abaji, still below the critical threshold. Participant refusal rates were minimal, reflecting strong community support and engagement.
The findings provide compelling evidence of significant progress toward LF elimination in Nigeria's FCT; however, the single positive case in Abaji underscores the continued importance of vigilant surveillance and integrated vector-management strategies to maintain elimination status and guard against residual transmission.
尼日利亚联邦首都地区(FCT)于2011年在其四个淋巴丝虫病(LF)流行区议会开展了年度大规模药物给药(MDA),实现了持续的高覆盖率,并在传播前评估调查中取得成功。本研究旨在确认布瓦里和瓜瓜尔达的传播是否中断,并评估阿巴吉和库杰在MDA后的监测效果。
在FCT内的四个不同评估单元(EUs)系统地开展了传播评估调查(TAS)。TAS 1在布瓦里和瓜瓜尔达评估单元进行,这两个单元最近达到了TAS前阈值,表明传播可能中断;而TAS 2在阿巴吉和库杰评估单元进行,自2021年TAS 1评估成功后,这两个单元已停止MDA。使用雅培丝虫检测试纸(FTS)对选定学校中6至7岁的儿童进行检测。数据收集遵循世界卫生组织的标准化指南,使用纸质和电子数据采集工具,以提高准确性并减少人为错误。
四个评估单元共有6448名儿童参与调查,性别分布接近平衡(男性占53%,女性占47%)。在TAS 1(布瓦里和瓜瓜尔达)中,未发现LF阳性病例,远低于世界卫生组织定义的18例的临界值。在TAS 2(阿巴吉和库杰)中,在阿巴吉检测到一例LF阳性病例,仍低于临界阈值。参与者的拒绝率极低,反映出社区的大力支持和参与。
研究结果提供了令人信服的证据,表明尼日利亚FCT在消除LF方面取得了重大进展;然而,阿巴吉的一例阳性病例凸显了持续进行警惕监测和综合病媒管理策略的重要性,以维持消除状态并防范残余传播。